Prenatal Diagnostic Market to Reach $24,857.4 million in 2035, Growing at 8.0% CAGR

Prenatal diagnostic market valued at $11,500.3 million in 2025 and is projected to reach $24,857.4 million by 2035, growing at a CAGR of 8.0% during the forecast period (2026-2035). The market encompasses a wide range of diagnostic tests and screening procedures used to detect genetic abnormalities, chromosomal disorders, and congenital conditions during pregnancy. The market is experiencing steady global growth driven by the increasing prevalence of genetic disorders, rising maternal age, and growing awareness regarding early prenatal screening. Expansion is further supported by technological advancements in non-invasive prenatal testing (NIPT), which offer higher accuracy with reduced risk compared to traditional invasive methods. Governments and healthcare organizations are actively promoting maternal and fetal health programs, contributing to higher adoption of prenatal diagnostics. Additionally, increasing access to advanced healthcare infrastructure in emerging economies and rising investments in molecular diagnostics are strengthening market growth. According to global health organizations, the rising number of pregnancies worldwide combined with increasing focus on early detection of fetal abnormalities has significantly strengthened demand for prenatal diagnostic services. Large-scale maternal health datasets, screening programs, and population health monitoring initiatives are playing a critical role in improving diagnostic accuracy, optimizing clinical decision-making, and ensuring better pregnancy outcomes globally.

Browse the full report description of “Prenatal Diagnostic Market Size, Share & Trends Analysis Report by Method (Blood, Urine, Ultrasound, Amniocentesis, and Others), and By Test Type (Invasive, and Non-Invasive), and By End-User (Hospitals, Specialty Clinics, and Diagnostic Centers) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/prenatal-diagnostic-market

Key Statistics: Prenatal Diagnostic Market at a Glance

• Approximately 140 million births occur globally each year, forming a substantial target population for prenatal diagnostic testing.
• About 3–6% of infants worldwide are born with serious birth defects, driving demand for early screening and diagnostic solutions.
• Non-invasive prenatal testing (NIPT) adoption has increased significantly, with detection accuracy rates exceeding 99% for common chromosomal abnormalities

Key Innovators Driving Prenatal Diagnostic Transformation

The key players in the prenatal diagnostic market include BGI Genomics Co., Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Thermo Fisher Scientific Inc, among others.

• In June 2025, Illumina, Inc. introduced its advanced NIPT platform, designed to improve detection accuracy for rare chromosomal abnormalities while broadening access to comprehensive prenatal genetic screening.
• In April 2025, Roche Diagnostics launched an enhanced non-invasive prenatal testing solution that incorporates AI-powered analytics to enable quicker, more precise risk assessments, supporting better clinical decision-making and patient outcomes.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Method
  • By Test Type
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - BGI Genomics Co., Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Prenatal Diagnostic Market Report Segment

By Method

• Blood
• Urine
• Ultrasound
• Amniocentesis
• Others

By Test Type

• Invasive
• Non-Invasive

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers

Global Prenatal Diagnostic Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/prenatal-diagnostic-market